PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.78%
Revenue growth above 1.5x 3088.T's 1.06%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
0.79%
Gross profit growth under 50% of 3088.T's 5.12%. Michael Burry would be concerned about a severe competitive disadvantage.
-4.47%
Negative EBIT growth while 3088.T is at 37.47%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-1.53%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-4.66%
Negative net income growth while 3088.T stands at 41.08%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-4.66%
Negative EPS growth while 3088.T is at 23.71%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-4.66%
Negative diluted EPS growth while 3088.T is at 23.71%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
82.86%
10Y revenue/share CAGR above 1.5x 3088.T's 14.68%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
82.86%
5Y revenue/share CAGR above 1.5x 3088.T's 14.68%. David Dodd would look for consistent product or market expansions fueling outperformance.
63.59%
3Y revenue/share CAGR above 1.5x 3088.T's 17.35%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
100.00%
Positive long-term OCF/share growth while 3088.T is negative. John Neff would see a structural advantage in sustained cash generation.
100.00%
Positive OCF/share growth while 3088.T is negative. John Neff might see a comparative advantage in operational cash viability.
100.00%
Positive 3Y OCF/share CAGR while 3088.T is negative. John Neff might see a big short-term edge in operational efficiency.
201.34%
Net income/share CAGR above 1.5x 3088.T's 76.12% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
201.34%
5Y net income/share CAGR above 1.5x 3088.T's 76.12%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
123.76%
3Y net income/share CAGR above 1.5x 3088.T's 76.59%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
126.65%
10Y equity/share CAGR above 1.5x 3088.T's 28.34%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
126.65%
5Y equity/share CAGR above 1.5x 3088.T's 28.34%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
85.78%
3Y equity/share CAGR above 1.5x 3088.T's 18.87%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-42.86%
Firm’s AR is declining while 3088.T shows 23.22%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-7.86%
Inventory is declining while 3088.T stands at 6.89%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-6.20%
Negative asset growth while 3088.T invests at 2.30%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.97%
BV/share growth above 1.5x 3088.T's 2.62%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-22.28%
We’re deleveraging while 3088.T stands at 1.37%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
1.48%
SG&A declining or stable vs. 3088.T's 1373.17%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09